A powerful new analytical tool offers a closer look at how tumor cells “shape-shift” to become more aggressive and untreatable, as shown in a study from researchers at Weill Cornell Medicine and the New York Genome Center.
The exhibition "Seeds of Survival and Celebration: Plants and the Black Experience" returned for a second season with an expanded plant collection, which honors the lasting influence of the formerly enslaved and their descendants on American culture.
A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease.
The collection of essays by Shepley and other authors is intended for students, academics and practitioners in all design fields to inspire societal contribution and celebrate collaboration.
A decline in estrogen during menopause causes changes in body fat distribution and associated cardiovascular and metabolic disease, but a new Cornell-led study identifies potential therapies that might one day reverse these unhealthy shifts.
Feuerstein has founded several digital health companies and is the executive director and founder of Yale School of Medicine’s Center for Digital Health and Innovation.
The FDA has approved tirzepatide – which will be sold under the brand name Zepbound – to treat overweight and obesity. It’s the latest entrant into a field of powerful new drugs that includes Ozempic and Wegovy.
A new study that tracks how many asthma-related emergency room visits result from pollen in metropolitan areas across Central Texas highlights the importance of knowing local plants and the need for developing science-based pollen forecasts.
